Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | TURNSTONE BIOLOGICS CORP | $2,166,925 | – | 549,981 | – | 14.52% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ENTRADA THERAPEUTICS INC | $7,706,608 | – | 509,023 | – | 60.04% | – | |
| New | CARIBOU BIOSCIENCES INC | $2,014,785 | – | 474,067 | – | 15.70% | – | |
| New | OMEGA THERAPEUTICS INC | $1,976,470 | – | 352,941 | – | 15.40% | – | |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $1,137,344 | – | 988,995 | – | 8.86% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | OMEGA THERAPEUTICS INC | $0 | – | -352,941 | – | -1.52% | – | |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -988,995 | – | -1.78% | – |
| Exit | CARIBOU BIOSCIENCES INC | $0 | – | -474,067 | – | -3.96% | – | |
| Exit | ENTRADA THERAPEUTICS INC | $0 | – | -509,023 | – | -6.36% | – | |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -1,848,024 | – | -86.39% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $52,170,000 | – | 1,848,024 | – | 80.62% | – |
| New | ENTRADA THERAPEUTICS INC | $6,200,000 | – | 509,023 | – | 9.58% | – | |
| New | CARIBOU BIOSCIENCES INC | $2,574,000 | – | 474,067 | – | 3.98% | – | |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $2,423,000 | – | 988,995 | – | 3.74% | – |
| New | OMEGA THERAPEUTICS INC | $1,341,000 | – | 352,941 | – | 2.07% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | OMEGA THERAPEUTICS INC | $0 | – | -352,941 | – | -8.31% | – | |
| Exit | CARIBOU BIOSCIENCES INC | $0 | – | -474,067 | – | -14.13% | – | |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -988,995 | – | -22.84% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -1,848,024 | – | -54.72% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | CARIBOU BIOSCIENCES INC | $11,316,000 | – | 474,067 | – | 14.13% | – | |
| New | OMEGA THERAPEUTICS INC | $6,653,000 | – | 352,941 | – | 8.31% | – |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $45,387,000 | – | 1,848,024 | – | 71.51% | – |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $18,079,000 | – | 988,995 | – | 28.49% | – |